Drug Profile
Ezetimibe/rosuvastatin - Ildong Pharmaceutical
Alternative Names: DropTop; Rosuvastatin/ezetimibe - Ildong PharmaceuticalLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Ildong Pharmaceutical
- Class Antihyperlipidaemics; Azetidines; Fluorobenzenes; Phenols; Propanols; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action Cholesterol absorption inhibitors; HMG-CoA reductase inhibitors; NPC1L1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypercholesterolaemia
Most Recent Events
- 01 Feb 2017 IlDong Pharmaceutical completes the phase III I-ROSETTE trial for Hypercholesterolaemia (In adults, In the elderly) in South Korea (PO) (NCT02749994)
- 06 May 2016 Chemical structure information added
- 01 Apr 2016 IlDong Pharmaceutical initiates the phase III I-ROSETTE trial for Hypercholesterolaemia (In adults, In the elderly) in South Korea (PO) (NCT02749994)